Patents Assigned to UNIVERSITE DE LA MEDITARRANEE AIX-MARSEILLE II
  • NUCLEIC ACIDS TARGETING TCTP FOR USE IN THE TREATMENT OF CHEMO-OR HORMONE- RESISTANT CANCERS
    Publication number: 20150216891
    Abstract: The present invention concerns a TCTP antagonist, in particular a nucleic acid targeting an m RNA encoding Translationally-Controlled Tumor Protein (TCTP), wherein said nucleic acid is capable of reducing the amount of TCTP in cells, for use in the treatment or prevention of hormone-independent cancer or chemo-resistant cancer, such as an androgen-independent prostate cancer.
    Type: Application
    Filed: April 16, 2015
    Publication date: August 6, 2015
    Applicants: Institut National De La Sante Et De La Recherche Medicale (Inserm), UNIVERSITE DE LA MEDITARRANEE AIX-MARSEILLE II
    Inventors: Palma ROCCHI, Virginie BAYLOT, Julie ACUNZO, Claudia ANDRIEU, Maria KATSOGIANNOU
  • NUCLEIC ACIDS TARGETING TCTP FOR USE IN THE TREATMENT OF CHEMO-OR HORMONE- RESISTANT CANCERS
    Publication number: 20130266572
    Abstract: The present invention concerns a TCTP antagonist, in particular a nucleic acid targeting an m RNA encoding Translationally-Controlled Tumor Protein (TCTP), wherein said nucleic acid is capable of reducing the amount of TCTP in cells, for use in the treatment or prevention of hormone-independent cancer or chemo-resistant cancer, such as an androgen-independent prostate cancer.
    Type: Application
    Filed: December 19, 2011
    Publication date: October 10, 2013
    Applicant: UNIVERSITE DE LA MEDITARRANEE AIX-MARSEILLE II
    Inventors: Palma Rocchi, Virginie Baylot, Julie Acunzo, Claudia Andrieu, Maria Katsogiannou